quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:15:00·109d
PRRelease
Processa Pharmaceuticals Inc. logo

Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study

PCSA· Processa Pharmaceuticals Inc.
Health Care
Original source

Companies

  • PCSA
    Processa Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Apr 25UpdateH.C. Wainwright$8.00
  • Aug 3UpdateOppenheimer$20.00
  • Aug 2UpdateOppenheimer$20.00

Related

  • INSIDER6d
    SEC Form 4 filed by Young David
  • INSIDER6d
    SEC Form 4 filed by Ng George K
  • INSIDER6d
    SEC Form 4 filed by Lin Patrick
  • INSIDER6d
    SEC Form 4 filed by Guy Wendy
  • INSIDER6d
    SEC Form 4 filed by Bigora Sian
  • INSIDER6d
    SEC Form 4 filed by Skibsted Russell
  • INSIDER21d
    SEC Form 4 filed by Neal James R
  • INSIDER22d
    SEC Form 4 filed by Young David
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022